Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database
Frontiers in Cardiovascular Medicine · 29.11.2023 · 10
DOI: 10.3389/fcvm.2023.1300839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 29.11.2023. Verfasst von Bryan Richard Sasmita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pharmacological support has become the mainstay therapy in patients with cardiogenic shock (CS). Unfortunately, the clinical benefits of such potent drugs remain unclear, therefore, the present study aims to elucidate the safety and efficacy of vasoactive agents in CS patients.
Methods
Medical Information Mart for Intensive Care (MIMIC) IV databases were used for this retrospective study. The primary outcome of this study was 30-day all-cause mortality. The subgroup analysis of was the relationship between the combined use of vasopressors and inotropes and 30-day all-cause mortality.
Results
A total of 2,216 patients diagnosed with CS were enrolled in this study. The non-survivors group was more likely to be older, presented with chronic kidney disease, have a lower systolic blood pressure, lower heart rate, and higher respiratory rate (all p < 0.05). In the multivariate Cox regression analysis, only dopamine [HR (95%CI): 1.219 (1.003–1.482)], norepinephrine [HR (95%CI): 2.528 (1.829–3.493)], and milrinone [HR (95%CI): 0.664 (0.512–0.861)] remained an independent predictor for 30-day all-cause mortality. Furthermore, a subgroup analysis was performed and found that no statistically significant difference between no vasopressor/inotrope use and 1 vasopressor/inotrope use ( p = 0.107). Meanwhile, a substantial deterioration of cumulative survival was observed when a combination of 2 or more vasopressors/inotropes was used in CS patients in comparison with no vasopressor/inotrope or only 1 vasopressor/inotrope use (all p < 0.05).
Conclusions
Using vasopressors/inotropes agents was associated with a higher risk of 30-day all-cause mortality in CS patients. In addition, only milrinone was associated with a better prognosis among the available vasoactive agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Medical Administration, The Sixth People's Hospital of Chongqing, Chongqing, China.
Zitieren
APA
Sasmita, B. R., Wang, C., & Xie, S. (2023). Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1300839
Vancouver
Sasmita BR, Wang C, Xie S. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1300839
BibTeX
@article{Sasmita2023,
author = {Sasmita, Bryan Richard and Wang, ChuanYing and Xie, Siyuan},
title = {Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1300839}
}
EUVIMED